Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > Chemotherapy
|
Buy Now
Clinically Relevant Resistance in Cancer Chemotherapy (Hardcover, 2002 ed.)
Loot Price: R2,852
Discovery Miles 28 520
|
|
Clinically Relevant Resistance in Cancer Chemotherapy (Hardcover, 2002 ed.)
Series: Cancer Treatment and Research, 112
Expected to ship within 10 - 15 working days
|
The introduction of new anticancer drugs and drug combinations, as
well as the use of high-dose chemotherapy with growth factor and
hemopoietic stem cell support, has greatly increased clinical
remission rates. Unfortunately palliation, rather than cure,
remains the most realistic goal of chemotherapy for many patients.
The failure to cure metastatic cancer is commonly attributed to
drug "resistance." Resistance can be broadly viewed as the survival
of malignant cells because of a failure to deliver an effective
drug dose to the (cellular) target, resulting from any one of or
combination of individual factors. For example, inter-individual
genetic differences in drug metabolism, as well as differences in
tumor kinetics and vascularization, may be important for treatment
outcome. In addition, numerous molecular mechanisms of resistance
have been elucidated at the level of the individual tumor cell.
The present volume reviews clinically relevant aspects of the
pharmacokinetics of commonly used anticancer agents as well as
mechanisms of cellular/experimental resistance to such agents. This
extends to technological advances that enable high-throughput
studies of genetic polymorphisms, which has opened up new avenues
to the study of drug resistance and to the individualization of
chemotherapy in order to decrease clinical toxicity and optimize
treatment results.
"This text provides a comprehensive review of the mechanisms of
resistance to cancer chemotherapuetic agents. Leading experts
discuss molecular and biochemical pathways that influence
cytotoxicity. Knowledge of these potential obstacles to therapy
will allow for the development of more effective strategies to
treat malignantdiseases."
Steven T. Rosen, M.D., Series Editor
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.